Lyme Disease: Why the Delay in Human Vaccines?
Richard Marconi, PhD, professor of microbiology and immunology at Virginia Commonwealth University Medical Center, explains why there has been a holdup in the development of a new human Lyme disease vaccine.
Richard Marconi, PhD, professor of microbiology and immunology at Virginia Commonwealth University Medical Center, explains why there has been a holdup in the development of a new human Lyme disease vaccine.
The previous human vaccine was taken off the market because of unfounded concerns, but this had a significant impact on the interests of big pharma to develop a new vaccine. Now, he says, there is significant interest in taking Lyme disease vaccines forward in the human market.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
